论文部分内容阅读
自1896年Biedl和Kraus报告将葡萄糖注射液静脉输注于人体以来,到现在已有八十多年了。至今,静脉输液制剂不断发展,简介如下:静脉输液制剂品种的增加静脉输液制剂可分为两大类:一为营养输液;一为代血浆输液。营养输液包括碳水化合物、脂肪和蛋白质三种主要成分,全输液营养还需要考虑维生素、电解质和微量元素等。从表面上看来,静脉输入营养物质和经口摄入营养物质只是途径不同,实际上更重要的
It has been more than eighty years since Biedl and Kraus reported intravenous glucose injections in humans in 1896. To date, intravenous infusion formulations continue to evolve, as described below: Variety of intravenous infusion formulations Increased intravenous infusion formulations can be divided into two categories: one for nutritional infusion; one for the generation of plasma infusion. Nutritional Infusion, including carbohydrate, fat and protein three main components of the whole infusion of nutrients also need to consider vitamins, electrolytes and trace elements. On the face of it, it is actually more important that nutrients are administered intravenously and taken orally in a way that is different